Covaxin Approval
- All
- News
- Videos
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Government Rubbishes Reports On Approval For Covaxin Due To Political Pressure
The Union Health Ministry today termed as "misleading" and "fallacious" media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Japan Approves Covaxin Booster Dose For Travellers: Bharat Biotech
Bharat Biotech on Friday said Japan has approved Covaxin booster dosage for travellers visiting the country.
-
"Portrays Incorrect Picture": Government On Reports Of Covaxin Concern
Centre said that reports apparently quoting a communication from the MEA asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval nod for its COVID jab, "potrayed an incorrect picture."
-
"Bharat Biotech Must Address WHO's Covaxin Suspension To Avoid...": Centre
Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.
-
Covaxin Maker Bharat Biotech's Nasal Booster Dose Trials Get Approval
Vaccine manufacturer Bharat Biotech has received approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin.
-
Covishield, Covaxin To Be Available In Hospitals, Clinics In New Approval
Covishield and Covaxin have been cleared by India's drugs regulator for sale in the market, sources have said.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
-
An Approval That Suggests Big Changes In Booster Policy Are Likely
Covaxin and Covishield could be more widely available with a new government approval that also suggests changes in rules for booster doses. Both vaccines have been cleared for "full use" by an expert panel of the central drug authority, a year after
-
Covishield, Covaxin Cleared For Market Approval By Expert Panel
An expert panel of India's central drug authority today recommended granting regular market approval to Covishield and Covaxin, which are currently only authorised for emergency use in the country, subject to certain conditions, official sources said
-
Covaxin Cleared For Children Above 12 By Drug Regulator
Bharat Biotech's COVID-19 vaccine Covaxin has been approved for emergency use on children between the ages of 12 and 18 by the Drugs Controller General of India (DCGI), sources said.
-
Central Drug Regulator Approves Shelf Life Of COVID-19 Vaccines CoviShield, Covaxin, ZyCoV-D
The Central Drugs Standard Organisation (CDSO) has approved the shelf life of COVID-19 vaccines Covaxin to 12 months, Covishield to nine months, and ZyCoV-D to six months from the date of manufacture, the Lok Sabha was informed on Friday.
-
Covaxin Cleared By UK, Relief For Indian Students And Tourists
China and India's Covid vaccines have been approved by the U.K. for travel into the country, clearing the way for tourists and foreign students who have been fully immunized with them to enter.
-
'Awaiting Lifting Of Curbs...': New Zealand's Nod To Covaxin, Covishield
New Zealand has included Covaxin and Covishield to its list of eight approved vaccines, Indian High Commissioner to the country, Mukhtesh Pardeshi, said today.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Government Rubbishes Reports On Approval For Covaxin Due To Political Pressure
The Union Health Ministry today termed as "misleading" and "fallacious" media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Japan Approves Covaxin Booster Dose For Travellers: Bharat Biotech
Bharat Biotech on Friday said Japan has approved Covaxin booster dosage for travellers visiting the country.
-
"Portrays Incorrect Picture": Government On Reports Of Covaxin Concern
Centre said that reports apparently quoting a communication from the MEA asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval nod for its COVID jab, "potrayed an incorrect picture."
-
"Bharat Biotech Must Address WHO's Covaxin Suspension To Avoid...": Centre
Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.
-
Covaxin Maker Bharat Biotech's Nasal Booster Dose Trials Get Approval
Vaccine manufacturer Bharat Biotech has received approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin.
-
Covishield, Covaxin To Be Available In Hospitals, Clinics In New Approval
Covishield and Covaxin have been cleared by India's drugs regulator for sale in the market, sources have said.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
-
An Approval That Suggests Big Changes In Booster Policy Are Likely
Covaxin and Covishield could be more widely available with a new government approval that also suggests changes in rules for booster doses. Both vaccines have been cleared for "full use" by an expert panel of the central drug authority, a year after
-
Covishield, Covaxin Cleared For Market Approval By Expert Panel
An expert panel of India's central drug authority today recommended granting regular market approval to Covishield and Covaxin, which are currently only authorised for emergency use in the country, subject to certain conditions, official sources said
-
Covaxin Cleared For Children Above 12 By Drug Regulator
Bharat Biotech's COVID-19 vaccine Covaxin has been approved for emergency use on children between the ages of 12 and 18 by the Drugs Controller General of India (DCGI), sources said.
-
Central Drug Regulator Approves Shelf Life Of COVID-19 Vaccines CoviShield, Covaxin, ZyCoV-D
The Central Drugs Standard Organisation (CDSO) has approved the shelf life of COVID-19 vaccines Covaxin to 12 months, Covishield to nine months, and ZyCoV-D to six months from the date of manufacture, the Lok Sabha was informed on Friday.
-
Covaxin Cleared By UK, Relief For Indian Students And Tourists
China and India's Covid vaccines have been approved by the U.K. for travel into the country, clearing the way for tourists and foreign students who have been fully immunized with them to enter.
-
'Awaiting Lifting Of Curbs...': New Zealand's Nod To Covaxin, Covishield
New Zealand has included Covaxin and Covishield to its list of eight approved vaccines, Indian High Commissioner to the country, Mukhtesh Pardeshi, said today.
